Lungpacer Medical, Inc., CEO Doug Evans presented preclinical and clinical research on Lungpacer’s novel phrenic nerve pacing technology at the 2019 RIS Meeting. The Respiratory Innovation Summit unites the innovators, investors and clinicians who are leading the fight to create powerful new treatments for deadly and crippling diseases of the lungs and airways.
Lungpacer Medical, Inc. Presents at Respiratory Innovation Summit, May 2019, Dallas, Texas
- May 1, 2019
